Home/ marches MARCHESGenmab-AbbVie treatment reduces blood cancer progression riskThe therapeutic combination developed by Genmab and AbbVie laboratories has shown efficacy in reducing the risk of progression of these diseases.Published 6sem·1 sourceNotable·updated 6sem Lire en françaisListen≈ 11sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:Boursorama↗🧭Explore this topicGenmabAbbVie#cancer#médicament#oncologie#Genmab#AbbVie#biotechnologie#santéWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on October 5, 2026← Back to home